Midwest Professional Planners Ltd (MPPL)’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-16,626
Closed -$689K 96
2018
Q4
$689K Sell
16,626
-122
-0.7% -$5.06K 0.74% 36
2018
Q3
$700K Buy
16,748
+6,779
+68% +$261K 0.64% 38
2018
Q2
$343K Buy
9,969
+58
+0.6% +$1.98K 0.31% 65
2018
Q1
$334K Buy
9,911
+1,115
+13% +$38.3K 0.3% 63
2017
Q4
$302K Buy
+8,796
New +$300K 0.28% 72

Other funds holding PFE

Midwest Professional Planners Ltd (MPPL)'s PFE Position: Q1 2019 in Review

Midwest Professional Planners Ltd (MPPL) sold out of Pfizer (PFE) in Q1 2019, closing a stake of 16,626 shares — an estimated $689K sold.

Midwest Professional Planners Ltd (MPPL) first reported a position in PFE in Q4 2017 and held it in 5 quarters. The position peaked at $700K in Q3 2018. 2,391 funds tracked by Wall St. Rank hold PFE as of Q1 2019.

  • Midwest Professional Planners Ltd (MPPL) reported no remaining Pfizer position as of Q1 2019 after selling out during the quarter.
  • Midwest Professional Planners Ltd (MPPL) sold 16,626 Pfizer shares in Q1 2019, an estimated $689K.
  • Midwest Professional Planners Ltd (MPPL) first reported a position in Pfizer in Q4 2017 and held it in 5 quarters.
  • Midwest Professional Planners Ltd (MPPL)'s Pfizer position peaked at $700K in Q3 2018.
  • 2,391 funds tracked by Wall St. Rank held Pfizer as of Q1 2019.

Based on Midwest Professional Planners Ltd (MPPL)'s 13F filing for Q1 2019, filed 8 May 2019.